These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3446078)

  • 1. [Congenital toxoplasmosis, convulsions and overdose of pyrimethamine].
    Cheron G; Saint-Raymond A; Castot A
    Arch Fr Pediatr; 1987 Nov; 44(9):824. PubMed ID: 3446078
    [No Abstract]   [Full Text] [Related]  

  • 2. [Neonatal intoxication with pyrimethamine: risk due to the absence of pediatric formulation?].
    Genuini M; Freihuber C; Girard I; de Montgolfier I; Kieffer F; Mitanchez D
    Arch Pediatr; 2011 Oct; 18(10):1084-6. PubMed ID: 21885264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonfatal prolonged overdosage of pyrimethamine in an infant: measurement of plasma and urine levels using HPLC with diode-array detection.
    Tracqui A; Mikail I; Kintz P; Mangin P
    J Anal Toxicol; 1993; 17(4):248-50. PubMed ID: 8371558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis and treatment of congenital toxoplasmosis].
    Koskiniemi M
    Duodecim; 1993; 109(14):1260-4. PubMed ID: 8062703
    [No Abstract]   [Full Text] [Related]  

  • 5. [The significance of the results of serological tests carried out during pregnancy for the prevention and diagnosis of congenital toxoplasmosis].
    Lässker G; Degen R; Keller J
    Z Kinderheilkd; 1969; 105(2):132-41. PubMed ID: 5813227
    [No Abstract]   [Full Text] [Related]  

  • 6. Congenital toxoplasmosis.
    Ho E
    Nurs Times; 1985 Feb 27-Mar 5; 81(9):46-7. PubMed ID: 3845531
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of combined treatment of infantile toxoplasmosis with pyrimethamine (daraprim) and sulfonamides on the blood and bone marrow].
    Weissbach G
    Z Arztl Fortbild (Jena); 1965 Jan; 59(1):10-22. PubMed ID: 5885819
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of congenital toxoplasmosis. Clinical and biological results (author's transl)].
    Couvreur J; Nottin N; Desmonts G
    Ann Pediatr (Paris); 1980 Dec; 27(10):647-52. PubMed ID: 7212550
    [No Abstract]   [Full Text] [Related]  

  • 9. [Adverse effects of combined toxoplasmosis therapy with daraprim and sulfonamides].
    Krüger E; Gerschke G
    Padiatr Grenzgeb; 1969; 8(1):39-48. PubMed ID: 5382580
    [No Abstract]   [Full Text] [Related]  

  • 10. [Severe complications arising from the prescription of pyrimethamine for infants being treated for toxoplasmosis].
    Elmalem J; Poulet B; Garnier R; Frelon JH; Castot A
    Therapie; 1985; 40(5):357-9. PubMed ID: 4095694
    [No Abstract]   [Full Text] [Related]  

  • 11. [Toxoplasmosis in childhood. Clinical findings and conclusions for medical practice].
    Geisler E; Osswald P
    Munch Med Wochenschr; 1965 Aug; 107(33):1556-67. PubMed ID: 5897871
    [No Abstract]   [Full Text] [Related]  

  • 12. Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study.
    McLeod R; Boyer K; Karrison T; Kasza K; Swisher C; Roizen N; Jalbrzikowski J; Remington J; Heydemann P; Noble AG; Mets M; Holfels E; Withers S; Latkany P; Meier P;
    Clin Infect Dis; 2006 May; 42(10):1383-94. PubMed ID: 16619149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Congenital toxoplasmosis].
    Tonjum A; Lie SO
    Tidsskr Nor Laegeforen; 1970 Aug; 90(16):1534-7. PubMed ID: 5457803
    [No Abstract]   [Full Text] [Related]  

  • 14. The child with congenital toxoplasmosis.
    McLeod R; Boyer K; Roizen N; Stein L; Swisher C; Holfels E; Hopkins J; Mack D; Karrison T; Patel D; Pfiffner L; Remington J; Withers S; Meyers S; Aitchison V; Mets M; Rabiah P; Meier P
    Curr Clin Top Infect Dis; 2000; 20():189-208. PubMed ID: 10943525
    [No Abstract]   [Full Text] [Related]  

  • 15. Simultaneous determination of pyrimethamine, sulfadiazine and N-acetyl-sulfadiazine in plasma for monitoring infants in treatment of congenital toxoplasmosis.
    Johannessen JK; Christiansen I; Schmidt DR; Petersen E; Hansen SH
    J Pharm Biomed Anal; 2005 Jan; 36(5):1093-8. PubMed ID: 15620537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Congenital toxoplasmosis diagnosis, a cooperative effort of obstetrician and pediatrician].
    Fanghänel M; Meyfarth G; Molkentin K
    Zentralbl Gynakol; 1969 Jan; 91(1):22-31. PubMed ID: 5385230
    [No Abstract]   [Full Text] [Related]  

  • 17. [Limitations of prenatal treatment of congenital toxoplasmosis with a sulfadiazine-pyrimethamine combination].
    Boulot P; Pratlong F; Sarda P; Deschamps F; Hedon B; Laffargue F; Viala JL
    Presse Med; 1990 Mar; 19(12):570. PubMed ID: 2139220
    [No Abstract]   [Full Text] [Related]  

  • 18. [Sulfadiazine, pyrimethamine, spiramycin and folic acid in congenital toxoplasmosis].
    Sedan J
    Mars Med; 1967; 104(4):343-5. PubMed ID: 5621539
    [No Abstract]   [Full Text] [Related]  

  • 19. Population pharmacokinetics of pyrimethamine and sulfadoxine in children with congenital toxoplasmosis.
    Trenque T; Simon N; Villena I; Chemla C; Quereux C; Leroux B; Jaussaud R; Rémy G; Dupouy D; Millart H; Pinon JM; Urien S
    Br J Clin Pharmacol; 2004 Jun; 57(6):735-41. PubMed ID: 15151519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital toxoplasmosis: value of prenatal treatment with pyrimethamine-sulfadoxine combination.
    Villena I; Quereux C; Pinon JM
    Prenat Diagn; 1998 Jul; 18(7):754-6. PubMed ID: 9706662
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.